Skip to main content



Local Cdiff information for Minnesota

Minnesota

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Minnesota.



Local Cdiff information for Minnesota

Minnesota

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Minnesota.

Providers

Dr. Sahil Khanna MBBS, MS

Mayo Clinic, Rochester, MN
200 First Street SW
Rochester, 55905
507-284-2511
FMT Provider: Yes
VISIT WEBSITE >

Dr. Alexander Khoruts, MD

Professor of Medicine
M Health Fairview University of Minnesota Medical Center – East Bank
500 Harvard St SE
Clinic 1E
Minneapolis, 55455
612-273-3000
EMAIL DR. KHORUTS >
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 1267
Hospital Onset: 1267
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.79
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: Yes
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Jean Rainbow, RN, MPH
Minnesota Department of Health
Acute Disease Investigation and Control Section
P.O. Box 64975
St. Paul, 55164
(651) 201-5104
(651) 201-5743
EMAIL JEAN RAINBOW, RN, MPH >

CLINICAL TRIALS

Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection

Official Title: An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of Intestinal Microbiota Transplantation In Patients Undergoing Colon Resection
Trial No. NCT06370884
Type: Interventional
Recruitment: Recruiting
Sponsor: University of Minnesota
Contact: Kathryn Vera
612-625-5018
EMAIL
Gender: All
Age: 18 Years to 75 years

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

C. difficile Toxin Levels After Standard-of-Care Antibiotic Treatment

Official Title: A Prospective, Observational Study to Evaluate C. Difficile Toxin Levels in Stool in Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Trial No. NCT07250724
Type: Observational
Recruitment: Recruiting
Sponsor: Bactolife A/S
Contact: Jennifer C Truell, MA, MPH
Gender: All
Age: 18 Years and older

Freeze-dried Microbiota in Colon Resection Patients

Official Title: An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection
Trial No. NCT06692179
Type: Interventional
Recruitment: Recruiting
Sponsor: University of Minnesota
Contact: Surgery Clinical Trials Office, MPH
Gender: All
Age: 18 Years to 75 Years